Neema Yazdani, a Program in Biomolecular Pharmacology Ph.D. graduate student, has be selected to present a platform presentation at the Tuesday, November 10, 2015 Genome Science Institute’s (GSI) Annual Research Symposium. Neema’s presentation is entitled, ‘HnRNP H1 regulates the stimulant and addictive properties of methamphetamine: Transcriptomic and spliceomic analyses uncover novel neurodevelopmental mechanisms” and is based upon the research he is carrying out in the Laboratory of Addiction Genetics in the Department of Pharmacology & Experimental Therapeutics under the mentorship of Dr. Camron Bryant.
The GSI symposium will be held in Hiebert Lounge, L-14th Floor in the School of Medicine from 12:00 to 5:00 p.m. and will include both poster sessions from 12:30 to 2:30 p.m. and platform presentations from 2:30 to 4:30 p.m. The awards ceremony will immediate follow the platform presentations.
In his recent article, “Neurophysiology Charges Ahead,” Alan Dove reviews recent advances in electrophysiology and genetic approaches to neuroscience. The research of Dr. David Farb, Director and Principal Investigator of the Laboratory of Molecular Neurobiology in the Department of Pharmacology & Experimental Therapeutics at Boston University, among others, is highlighted. Noting the evolution of electrophysiology techniques, Dr. Farb discusses how these recent advances have increased the ability to measure brain activity which may lead to therapeutic discoveries for the treatment of neurodegenerative diseases such as Alzheimer’s disease. For more information on Dr. Farb’s research, please visit his website.
In This Issue:
- Message from the President: Dr Kenneth E. Thummel
- EB2016 Meeting Highlights
- Feature Article: Sleepy Sickness, Oliver Sacks, and the Early Days of L-Dopa
- Science Policy News
- Education News
- Journal News
- Membership News
- Members in the News
- Division News
- Chapter News
- Meetings and Congresses
Joon Ying Boon and Megan Varnum Participate in the 25th Annual BUMC Art Days and GMS Student Art Exhibit
Joon Ying Boon and Megan Varnum, Program in Biomolecular Pharmacology Ph.D. graduate students, contributed to the success of 25th Annual BUMC Art Days, March 30-31, 2015. BUMC students, faculty and staff were invited to contribute paintings, photos, poetry, sculpture, needlework, etc. for the event. This year’s keyword was INTERSECT and a special display section was set aside in Hiebert Lounge devoted to works focused on “Intersect.” On Tuesday, April 14, 2015, Joon’s and Megan’s art works were also displayed at a special exhibit sponsored by the Division of Graduate Medical Sciences featuring paintings and photographs by DGMS graduate students.
Joon Ying Boon has entitled her piece, “Grandfather Trees.” She explains that “somewhere in the overcrowded, busy and skyscrapers-filled urban Hong Kong, there is an old park with old trees where one can find peace and serenity.”
Joon is also a senior Ph.D. student pursing her dissertation research on the identification of proteins that bind to and regulate LRRK2 in the Laboratory of Neurodegeneration, under the mentorship of Principal Investigator and Professor of Pharmacology and Neurology, Benjamin Wolozin, M.D., Ph.D.
The banner painting above was done by Megan Varnum’s and is entitled, “A Mexican Hillside”. Megan elaborated on that, “Mexicans incorporate vibrant color into nearly every aspect of their culture, and I wanted to reflect that in this painting. Although I cannot personally take credit for taking the photo from which this was painted, it reminds me of the times my family would go to Mexico and how inspired I would be by all the colors.”
Megan is a senior Ph.D. student doing her dissertation research on traumatic brain injury (TBI) in the Laboratory of Molecular NeuroTherapeutics under the direction of mentor, Principal Investigator, and Professor of Pharmacology and Neurology, Tsuneya Ikezu, M.D., Ph.D.
These two aspiring young scientists inspire us with their creativity. Beautiful work, Joon and Megan!
Congratulations to Sanghee Lim on being awarded a 2015 Medical Student Research Grant from the Melanoma Research Foundation for his proposal, “Defining Novel Mechanisms of Genome Instability in Melanoma.” The Medical Student Research Grant is awarded for a one-year period in order “to provide opportunities and funding for medical students to engage in short clinical or laboratory-based research projects focused on better understanding the biology and treatment of melanoma.” Sanghee is one of six medical students who received the nationally competitive award this year.
An MD/PhD student Program in Biomolecular Pharmacology, Sanghee is working under the guidance of Dr. Neil Ganem, Assistant Professor of Pharmacology & Experimental Therapeutics and Medicine, in the Laboratory of Cancer Cell Biology at the Shamim and Ashraf Dahod Breast Cancer Research Laboratories. His work is aimed at defining the mechanisms that give rise to chromosome instability in human melanoma. In particular, Sanghee is testing whether activating mutations in the oncogene BRAF, which occur in ~80% of all melanomas, directly promote mitotic defects.
Great job, Sanghee! Keep up the great work.
Neema Yazdani is one of two graduate students selected for the 2015 “Outstanding Graduate Student Travel Award” for the 17th Annual International Behavioral and Neural Genetics Society (IBANGS) Meeting in Uppsala, Sweden. Neema is a third year PhD candidate and Program in Biomolecular Pharmacology student in the Laboratory of Addiction Genetics under the mentorship of Camron D. Bryant, Ph.D., Assistant Professor of Pharmacology and Psychiatry. As a recipient of this award, Neema is invited to present his research as an oral presentation titled, “Hnrnph1 is a quantitative trait gene for methamphetamine sensitivity”. Neema’s efforts in generating and phenotyping TALENs-targeted Hnrnph1 knockout mice combined with striatal transcriptome analysis via RNA-seq led to the identification of Hnrnph1 as a novel quantitative trait gene involved in the stimulant response to methamphetamine. His transcriptome results suggest that Hnrnph1 could regulate the neural development of the mesocorticolimbic circuitry which would have widespread implications for understanding the etiology of a variety of neurobiological disorders involving a dysregulation of dopamine transmission.
Dr. Carol Walsh Presents BUSDM Dental Pharmacology Integrated Problem Session to ADEA Annual Meeting
Carol Walsh, Ph.D., Pharmacology Vice Chair for Education, presented a description of the innovative Integrated Problem Sessions of the BUSDM Dental Pharmacology course at a symposium held March 9 at the American Dental Education Association (ADEA) annual meeting in Boston. The symposium, organized by Aldo Leone, D.M.D.,Associate Dean for Academic Affairs at BUSDM, was entitled “Igniting Minds through Student Self-directed Group Learning: Integrated Problem Sessions” and included presentations by Dr. Leone, Drs. Whitney and Pessina from the Anatomy and Neurobiology Department, and Dr. Sarita-Reyes from the Pathology Department. The presenters were honored by special recognition of the symposium by the Chair of the ADEA Board of Directors.
University-wide Graduate Program for Neuroscience Receives BU Provost’s CEIT Interdisciplinary Course Development Grant
Congratulations go to Shelley J. Russek, Ph.D., Professor Pharmacology & Experimental Therapeutics and Biology, and the University-wide Graduate Program for Neuroscience (GPN) on being awarded the Boston University Provost’s Center for Excellence and Innovation in Teaching (CEIT) Interdisciplinary Course Development Grant. As GPN Director, Shelley spearheads a university-wide team of outstanding faculty who do an exceptional job in preparing graduate students for careers in neuroscience.
GPN is a University-wide Ph.D. degree granting program uniting the graduate training faculty of the BU Charles River Campus and the BU Medical Campus to serve as the nexus point for all neuroscience training missions at Boston University.
Neil J. Ganem, Ph.D., Assistant Professor of Pharmacology & Experimental Therapeutics and Medicine at the Boston University School of Medicine, has received a 2014 Smith Family Foundation Award for Excellence in Biomedical Research.
This prestigious, highly competitive three-year award of $300,000 is intended to help launch the careers of newly independent biomedical researchers. Since 1992, the program has funded 130 investigators for a total investment of $23 million. Applications focus on all fields of basic biomedical science as well as research in physics, chemistry and engineering. Applicants, who are nominated by their institutions, must be full-time faculty at nonprofit academic, medical, or research institutions.
Dr. Ganem received his Ph.D. from the Geisel School of Medicine at Dartmouth and was a postdoctoral fellow at the Dana-Farber Cancer Institute/Harvard Medical School. His research focuses on the causes and consequences of chromosomal instability, broadly defined as the persistent acquisition of both numerical and structural chromosomal aberrations. Chromosomal instability is a hallmark of solid cancers and is known to facilitate tumor initiation, progression, and relapse. The Smith Family Foundation Award will support Dr. Ganem’s research to examine how cancer cells adapt to abnormal chromosomal content.
Boston University Medical Campus is located in the historic South End of the capital city of Massachusetts. Well-known for the high quality of teaching, research, and community service, the school provides an exceptional learning environment for its students in the heart of the city.
Article originally posted on BestMedicalDegrees.com.